Esmirtazapine

Esmirtazapine (pronounced: es-mir-taz-a-peen) is a pharmaceutical drug under development for the treatment of insomnia and major depressive disorder.

The name "Esmirtazapine" is derived from the parent compound mirtazapine, a tetracyclic antidepressant, with the prefix "Es-" indicating the enantiomer of the compound that is used.

Esmirtazapine is a noradrenergic and specific serotonergic antidepressant (NaSSA). It works by blocking specific serotonin and norepinephrine receptors in the brain, which helps to improve mood and sleep.

Mirtazapine: The parent compound of Esmirtazapine. It is a tetracyclic antidepressant used in the treatment of major depressive disorder and anxiety disorders.
Insomnia: A sleep disorder that is characterized by difficulty falling and/or staying asleep.
Major depressive disorder: A mental health disorder characterized by persistently depressed mood or loss of interest in activities, causing significant impairment in daily life.
Enantiomer: One of two stereoisomers that are mirror images of each other that are non-superposable.
Serotonin: A neurotransmitter that helps regulate mood and social behavior, appetite and digestion, sleep, memory, and sexual desire and function.
Norepinephrine: A neurotransmitter that is important for attentiveness, emotions, sleeping, dreaming, and learning.

This WikiMD article is a stub. You can help make it a full article.

Languages: - East Asian 中文, 日本, 한국어, South Asian हिन्दी, Urdu, বাংলা, తెలుగు, தமிழ், ಕನ್ನಡ,
Southeast Asian Indonesian, Vietnamese, Thai, မြန်မာဘာသာ, European español, Deutsch, français, русский, português do Brasil, Italian, polski

Navigation menu